Ocean Biomedical, Inc.

Ocean Biomedical, Inc. trades under the ticker AEHA following its business combination with Aesther Healthcare Acquisition Corp., a blank-check company sponsored by Aesther Healthcare Holdings, LLC that completed its IPO in 2021 targeting the healthcare and life sciences sector. The February 2023 8-K filing reflects activity surrounding the closing of that de-SPAC transaction, through which Ocean Biomedical — a Providence, Rhode Island-based biopharmaceutical company with research ties to Brown University focused on oncology, pulmonary fibrosis, and infectious disease — became a publicly traded entity. The combined company is currently listed on Nasdaq. Visit SpacDesk and sign up for full data on AEHA, its filings, and the complete SPAC universe.